GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » PB Ratio

QTTB (Q32 Bio) PB Ratio : 4.39 (As of Mar. 25, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-25), Q32 Bio's share price is $2.04. Q32 Bio's Book Value per Share for the quarter that ended in Dec. 2024 was $0.47. Hence, Q32 Bio's PB Ratio of today is 4.39.

The historical rank and industry rank for Q32 Bio's PB Ratio or its related term are showing as below:

QTTB' s PB Ratio Range Over the Past 10 Years
Min: 1.33   Med: 6.85   Max: 33.57
Current: 4.34

During the past 4 years, Q32 Bio's highest PB Ratio was 33.57. The lowest was 1.33. And the median was 6.85.

QTTB's PB Ratio is ranked worse than
74.43% of 1283 companies
in the Biotechnology industry
Industry Median: 2.38 vs QTTB: 4.34

Back to Basics: PB Ratio


Q32 Bio PB Ratio Historical Data

The historical data trend for Q32 Bio's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio PB Ratio Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24
PB Ratio
- - - 7.40

Q32 Bio Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 4.17 6.42 29.61 7.40

Competitive Comparison of Q32 Bio's PB Ratio

For the Biotechnology subindustry, Q32 Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q32 Bio's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's PB Ratio distribution charts can be found below:

* The bar in red indicates where Q32 Bio's PB Ratio falls into.



Q32 Bio PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Q32 Bio's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=2.04/0.465
=4.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Q32 Bio  (NAS:QTTB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Q32 Bio PB Ratio Related Terms

Thank you for viewing the detailed overview of Q32 Bio's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Q32 Bio Business Description

Traded in Other Exchanges
N/A
Address
830 Winter Street, Waltham, MA, USA, 02451
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.